Home > Healthcare > Medical Devices > Diagnostic Devices > In-vitro Toxicology Testing Market

In-vitro Toxicology Testing Market Size

Report ID: GMI5543
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

In-vitro Toxicology Testing Market Size

In-vitro Toxicology Testing Market size was valued at around USD 1.9 Billion in 2023 and is anticipated to register a CAGR of over 7.7% between 2024 and 2032. In-vitro toxicology testing refers to the scientific evaluation of the toxic effects of substances (such as chemicals, drugs, or other compounds) on biological systems outside of a living organism.

To get key market trends

Download Free Sample

The in-vitro toxicology testing market is witnessing remarkable growth, driven by a confluence of factors shaping the pharmaceutical, chemical, and cosmetics industries. One of the primary drivers of market growth is the increasing regulatory scrutiny and stringent safety requirements imposed by governmental bodies worldwide. These regulations compel industries to adopt safer and more reliable testing methods, propelling the demand for in-vitro toxicology testing solutions.

Moreover, the incorporation of in-vitro toxicology testing in drug development and product safety assessment processes by pharmaceutical and cosmetics companies signifies a significant shift in industry practices. This transformation is driven by various factors that collectively contribute to advancing scientific methods, enhancing ethical considerations, and streamlining research and development efforts.

Additionally, advancements in technology, such as high-throughput screening and organ-on-a-chip models, are enhancing the efficiency and accuracy of in-vitro toxicology testing, further fueling market progress.

In-vitro Toxicology Testing Market Report Attributes
Report Attribute	Details
Base Year:	2023
In-vitro Toxicology Testing Market Size in 2023:	USD 1.9 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	7.7%
2024 – 2032 Value Projection:	USD 3.6 Billion
Historical Data for:	2018 – 2023
No. of Pages:	270
Tables, Charts & Figures:	417
Segments covered:	Product and Services, Endpoint and Test, Technology, Industry, Method, and Region
Growth Drivers:	Rise in government funding for toxicology research Increased R&D investments Technological advancements Growing resistance against animal testing
Pitfalls & Challenges:	Stringent regulatory restrictions Lack of in-vitro models to study complex end-points

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

In-vitro toxicology testing industry reached USD 1.9 billion in revenue in 2023 and is projected to surpass USD 3.6 billion by 2032 attributed to increasing incorporation in drug development and product safety assessment processes by pharmaceutical and cosmetics companies.

The cell culture technology segment is poised for significant growth at 7.8% CAGR during 2024-2032 attributed to the increasing use of organoids, which are three-dimensional, miniature organs grown in vitro.

North America in-vitro toxicology testing market generated USD 857.2 million in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the notable trend toward the increased adoption of in-vitro testing methods as an alternative to traditional animal testing.

Some of the top firms engaged in the in-vitro toxicology testing industry are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Catalent, Inc., Danaher Corporation, Eurofins Scientific, Evotec S.E., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc., among others.